Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 15.51% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Reynolds Consumer Products
REYN
$5.6B
| $851K | ﹤0.01% |
28,400
-10,900
| -28% | -$327K |
|
2627
State Street
STT
$51B
| $850K | ﹤0.01% |
10,961
-190,539
| -95% | -$14M |
|
2628
ONE Gas
OGS
$5.04B
| $848K | ﹤0.01% |
+11,200
| New | +$864K |
|
|
LOMA
2629
Loma Negra
LOMA
$1.19B
| $846K | ﹤0.01% |
123,500
+112,500
| +1,023% | +$727K |
|
2630
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$18.9B
| $846K | ﹤0.01% |
19,900
+3,800
| +24% | +$161K |
|
|
AZRE
2631
DELISTED
Azure Power Global Limited
AZRE
| $844K | ﹤0.01% |
195,796
-20,300
| -9% | -$106K |
|
|
LUMO
2632
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $842K | ﹤0.01% |
233,114
-17,399
| -7% | -$114K |
|
|
AINC
2633
DELISTED
Ashford Inc.
AINC
| $842K | ﹤0.01% |
60,653
-12,000
| -17% | -$179K |
|
2634
Curis
CRIS
$7.91M
| $841K | ﹤0.01% |
3,822
-1,350
| -26% | -$396K |
|
|
SY
2635
So-Young International
SY
$217M
| $841K | ﹤0.01% |
652,128
-218,033
| -25% | -$165K |
|
2636
abrdn Physical Precious Metals Basket Shares ETF
GLTR
$2.67B
| $839K | ﹤0.01% |
9,400
-4,400
| -32% | -$372K |
|
2637
iShares Core S&P Small-Cap ETF
IJR
$113B
| $833K | ﹤0.01% |
+8,800
| New | +$844K |
|
2638
Legacy Housing
LEGH
$695M
| $833K | ﹤0.01% |
43,954
-20,088
| -31% | -$353K |
|
2639
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.44B
| $832K | ﹤0.01% |
+7,700
| New | +$847K |
|
2640
Interface
TILE
$2.28B
| $832K | ﹤0.01% |
84,300
-34,184
| -29% | -$359K |
|
2641
iShares US Consumer Staples ETF
IYK
$1.41B
| $831K | ﹤0.01% |
12,300
+6,300
| +105% | +$415K |
|
2642
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
$1.28B
| $830K | ﹤0.01% |
9,500
-6,200
| -39% | -$555K |
|
2643
Boston Omaha
BOC
$437M
| $829K | ﹤0.01% |
31,300
-9,900
| -24% | -$260K |
|
2644
WisdomTree International SmallCap Dividend Fund
DLS
$1.08B
| $829K | ﹤0.01% |
+14,300
| New | +$794K |
|
2645
AC Immune
ACIU
$240M
| $826K | ﹤0.01% |
404,679
-30,200
| -7% | -$77.8K |
|
2646
Ocular Therapeutix
OCUL
$2.01B
| $826K | ﹤0.01% |
293,993
+279,200
| +1,887% | +$924K |
|
2647
Outset Medical
OM
$89.3M
| $826K | ﹤0.01% |
2,133
-1,194
| -36% | -$337K |
|
|
RAD
2648
DELISTED
Rite Aid Corporation
RAD
| $826K | ﹤0.01% |
247,300
-56,400
| -19% | -$268K |
|
|
MMX
2649
DELISTED
Maverix Metals Inc. Common Shares
MMX
| $825K | ﹤0.01% |
176,200
-96,382
| -35% | -$372K |
|
2650
Prelude Therapeutics
PRLD
$385M
| $824K | ﹤0.01% |
136,500
-6,900
| -5% | -$44.2K |
|
Similar funds
Renaissance Technologies's Q4 2022 Portfolio in Review
As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
- Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
- Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.